Disclosure of the use of FasL antagonist, e.g. of humanized antibodies directed against human Fas Ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigus

Remedies for pemphigus containing anti Fas Ligand antibodies / Pincelli, Carlo; Marconi, Alessandra. - (2007 Dec 12).

Remedies for pemphigus containing anti Fas Ligand antibodies

PINCELLI, Carlo;MARCONI, Alessandra
2007

Abstract

Disclosure of the use of FasL antagonist, e.g. of humanized antibodies directed against human Fas Ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigus
12-dic-2007
18-giu-2009
PinCell srl
WO 2009/074339 A1
Pincelli, Carlo; Marconi, Alessandra
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/615548
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact